Free shipping on all orders over $ 500

CH5138303

Cat. No. M3776

All AbMole products are for research use only, cannot be used for human consumption.

CH5138303 Structure
Size Price Availability
2mg USD 110  USD110 Out of stock
5mg USD 200  USD200 Out of stock
10mg USD 350  USD350 Out of stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

CH5138303 is an orally available Hsp90 inhibitor with Kd of 0.48 nM. CH5138303 showed high binding affinity for N-terminal Hsp90α (Kd=0.52nM) and strong in vitro cell growth inhibition against human cancer cell lines (HCT116 IC50=0.098μM, NCI-N87 IC50=0.066μM) and also displayed high oral bioavailability in mice (F=44.0%) and potent antitumor efficacy in a human NCI-N87 gastric cancer xenograft model (tumor growth inhibition=136%).

Protocol (for reference only)
Cell Experiment
Cell lines HCT116 and NCI-N87 cell lines
Preparation method Culturing HCT116 cell line and NCI-N87 cell line according to the supplier’s instructions. Suspending cells in a medium are added to solutions which contains various concentrations of the test substance, and culturing the cells at 37 °C in 5% CO2. Four days later, adding cell Counting Kit-8 solution and measuring absorbance at 450 nm with Microplate-Reader iMark. Calculating antiproliferative activity by the formula (1−T/C) × 100 (%), where T represents the absorbance of drug-treated cells and C that of untreated control cells at 450 nm. Using Microsoft Excel 2007 to calculate the 50% inhibition concentration (IC50) values
Concentrations ~10 μM
Incubation time 4 days
Animal Experiment
Animal models Mice with human NCI-N87 gastric cancer xenograft.
Formulation
Dosages 50 mg/kg
Administration p.o.
Chemical Information
Molecular Weight 415.9
Formula C19H18ClN5O2S
CAS Number 959763-06-5
Solubility (25°C) DMSO
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Suda A, et al. Bioorg Med Chem. Design and synthesis of 2-amino-6-(1H,3H-benzo[de]isochromen-6-yl)-1,3,5-triazines as novel Hsp90 inhibitors.

Related HSP Products
NCT-58 

NCT-58 is a potent inhibitor of C-terminal HSP90.

Gedunin 

Gedunin is a limonoid with anti-cancer, anti-viral, anti-inflammatory and insecticidal activities.

VER-49009

VER-49009 is a Hsp90 inhibitor, with an IC50 of 25 nM and a Kd of 78 nM.

YUM70

YUM70 is a potent and selective inhibitor of glucose-regulated protein 78 (GRP78), with an IC50 of 1.5 μM for inhibiting GRP78 ATPase activity. YUM70 induces endoplasmic reticulum stress-mediated apoptosis in pancreatic cancer.

Hsp70-derived octapeptide

Hsp70-derived octapeptide is a conserved octapeptide of the C-terminal end of Hsp70, which physically interacts with tetratricopeptide repeat (TPR) motifs.

  Catalog
Abmole Inhibitor Catalog




Keywords: CH5138303 supplier, HSP, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.